🔗 Permalink

Inventor profile of:

Yang Liu

City:

Baltimore, Maryland

Country:

United States

Published Applications:

Last publication date:

2026-05-28

Top Assignees for applications by Yang Liu

The entities that hold a legal rights for patent applications filed by inventor Liu Yang:

OncoImmune, Inc. 7 Rockville, MD United States
CHILDREN'S RESEARCH INSTITUTE, CHILDREN'S NATIONAL MEDICAL CENTER 2 Washington, DC United States
ONCOC4, INC. 2 Rockville, MD United States
Oncolmmune, Inc. 2 Rockville, MD United States
University of Maryland ,Baltimore 2 Baltimore, MD United States
Institute of Biophysics Chinese Academy of Sciences 1 Beijing, China
BRISTOL-MYERS SQUIBB COMPANY 1 Princeton, NJ United States
UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL 1 Chapel Hill, NC United States
THE JOHNS HOPKINS UNIVERSITY 1 Baltimore, MD United States
KUNMING INSTITUTE OF ZOOLOGY, CHINESE ACADEMY OF SCIENCES 1 Yunnan, China

Recent patent applications by Liu Yang

Yang Liu from Baltimore, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-05-28

US20260144808A1

Human necessities

TREATMENT OF REPEAT EXPANSION DISEASE

#2 | 2025-01-02

US20250002991A1

Chemistry; metallurgy

METHODS AND COMPOSITIONS FOR GENOME EDITING

#3 | 2022-12-29

US20220411790A1

Chemistry; metallurgy

A CRISPR-CAS9 PLATFORM WITH AN INTRINSIC OFF-SWITCH AND ENHANCED SPECIFICITY

#4 | 2022-12-22

US20220403378A1

Chemistry; metallurgy

LIGHT-INDUCIBLE CRISPR/CAS9 SYSTEM FOR GENOME EDITING

#5 | 2022-05-05

US20220135619A1

Chemistry; metallurgy

METHODS OF ISOLATING A PROTEIN

#6 | 2021-09-02

US20210268061A1

Human necessities

Methods of use of CD24 for the prevention and treatment of leukemia relapse

#7 | 2021-07-29

US20210228680A1

Human necessities

METHODS OF USE OF CD24 FOR THE PREVENTION AND TREATMENT OF GRAFT VERSUS HOST DISEASE AND MUCOSITIS

#8 | 2021-07-15

US20210214458A1

Chemistry; metallurgy

Anti-CD24 compositions and uses thereof

#9 | 2021-06-03

US20210162006A1

Human necessities

Use of CD24 Proteins for Treating Leptin-Deficient Conditions

#10 | 2021-06-03

US20210161991A1

Human necessities

USES OF HYPOXIA-INDUCIBLE FACTOR INHIBITORS

#11 | 2021-02-18

US20210047410A1

Chemistry; metallurgy

METHODS OF SELECTING AND DESIGNING SAFER AND MORE EFFECTIVE ANTI-CTLA-4 ANTIBODIES FOR CANCER THERAPY

#12 | 2021-02-18

US20210046154A1

Human necessities

METHODS OF USE OF SOLUBLE CD24 FOR TREATING ACQUIRED IMMUNE DEFICIENCY SYNDROME (HIV/AIDS)

#13 | 2021-02-11

US20210040212A1

Chemistry; metallurgy

Mutant anti-CTLA-4 antibodies with improved immunotherapeutic effect but attenuated adverse effects

#14 | 2020-12-24

US20200399345A1

Chemistry; metallurgy

METHODS OF USE OF SOLUBLE CD24 FOR THERAPY OF RHEUMATOID ARTHRITIS

InventorID:

2942503 ⎘